Literature DB >> 15086715

The practicability of FIGO 2000 staging for gestational trophoblastic neoplasia.

H Y S Ngan1.   

Abstract

The FIGO 2000 gestational trophoblastic neoplasia (GTN) staging and classification has recommended three major changes in the management of GTN. The criteria for diagnosis of GTN following molar pregnancy were defined. The methods used for investigation of spread of the disease were recommended. A major change in the concept of FIGO staging in adding risk scoring to anatomical staging is novel but considered essential to best reflect the behavior of this disease which is different from other solid tumors. The history of evolution of this staging and classification system and practical points in applying this system were discussed. If this system would be used worldwide, it would be a big leap in the management of GTN where results can be compared among different centers and large multicenter trials would be possible.

Entities:  

Mesh:

Year:  2004        PMID: 15086715     DOI: 10.1111/j.1048-891X.2004.014236.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  15 in total

1.  Role of AhR in regulating cancer stem cell-like characteristics in choriocarcinoma.

Authors:  Chenchun Wu; Shuran Yu; Qianxia Tan; Peng Guo; Huining Liu
Journal:  Cell Cycle       Date:  2018-10-18       Impact factor: 4.534

2.  p21-Activated kinase-1 promotes aggressive phenotype, cell proliferation, and invasion in gestational trophoblastic disease.

Authors:  Michelle K Y Siu; Matthew C W Yeung; HuiJuan Zhang; Daniel S H Kong; Joanna W K Ho; Hextan Y S Ngan; Dominic C W Chan; Annie N Y Cheung
Journal:  Am J Pathol       Date:  2010-04-22       Impact factor: 4.307

3.  Overexpression of NANOG in gestational trophoblastic diseases: effect on apoptosis, cell invasion, and clinical outcome.

Authors:  Michelle K Y Siu; Esther S Y Wong; Hoi Yan Chan; Hextan Y S Ngan; Kelvin Y K Chan; Annie N Y Cheung
Journal:  Am J Pathol       Date:  2008-09-04       Impact factor: 4.307

4.  Can the FIGO 2000 scoring system for gestational trophoblastic neoplasia be simplified? A new retrospective analysis from a nationwide dataset.

Authors:  Y K Eysbouts; P B Ottevanger; L F A G Massuger; J IntHout; D Short; R Harvey; B Kaur; N J Sebire; N Sarwar; F C G J Sweep; M J Seckl
Journal:  Ann Oncol       Date:  2017-08-01       Impact factor: 32.976

5.  Major surgeries performed for gestational trophoblastic neoplasms in a teaching hospital in Tehran, Iran.

Authors:  Fatemeh Ghaemmaghami; Tahereh Ashrafgangooei; Mitra Modares Gillani; Asamosadat Mosavi; Nadereh Behtash
Journal:  J Gynecol Oncol       Date:  2011-06-30       Impact factor: 4.401

6.  A comparison of patients with relapsed and chemo-refractory gestational trophoblastic neoplasia.

Authors:  T Powles; P M Savage; J Stebbing; D Short; A Young; M Bower; C Pappin; P Schmid; M J Seckl
Journal:  Br J Cancer       Date:  2007-02-13       Impact factor: 7.640

7.  Management and prognosis of patients with brain metastasis from gestational trophoblastic neoplasia: a 24-year experience in Peking union medical college hospital.

Authors:  Changji Xiao; Junjun Yang; Jing Zhao; Tong Ren; Fengzhi Feng; Xirun Wan; Yang Xiang
Journal:  BMC Cancer       Date:  2015-04-28       Impact factor: 4.430

8.  Human chorionic gonadotrophin as an indicator of persistent gestational trophoblastic neoplasia.

Authors:  Soheila Aminimoghaddam; Fariba Yarandi; Forough Nejadsalami; Farrokh Taftachi; Fereshteh Noor Bakhsh; Fatemeh Mahmoudzadeh
Journal:  Med J Islam Repub Iran       Date:  2014-06-11

9.  Comparison of the efficacy of methotrexate and actinomycin D in the treatment of patients with stage I low risk gestational trophoblastic neoplasia (GTN).

Authors:  Nahid Shahbazian; Taghi Razi; Shima Razi; Leila Yazdanpanah
Journal:  Med J Islam Repub Iran       Date:  2014-07-22

10.  Hemoptysis as primary manifestation in three women with choriocarcinoma with pulmonary metastasis: a case series.

Authors:  Wenping Zhang; Bao Liu; Jizhen Wu; Beibei Sun
Journal:  J Med Case Rep       Date:  2017-04-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.